170 related articles for article (PubMed ID: 9579801)
1. Characterization of a mouse monoclonal IgG3 antibody to the tumor-associated globo H structure produced by immunization with a synthetic glycoconjugate.
Kudryashov V; Ragupathi G; Kim IJ; Breimer ME; Danishefsky SJ; Livingston PO; Lloyd KO
Glycoconj J; 1998 Mar; 15(3):243-9. PubMed ID: 9579801
[TBL] [Abstract][Full Text] [Related]
2. Polyclonal antibodies from patients immunized with a globo H-keyhole limpet hemocyanin vaccine: isolation, quantification, and characterization of immune responses by using totally synthetic immobilized tumor antigens.
Wang ZG; Williams LJ; Zhang XF; Zatorski A; Kudryashov V; Ragupathi G; Spassova M; Bornmann W; Slovin SF; Scher HI; Livingston PO; Lloyd KO; Danishefsky SJ
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2719-24. PubMed ID: 10716997
[TBL] [Abstract][Full Text] [Related]
3. A novel and efficient method for synthetic carbohydrate conjugate vaccine preparation: synthesis of sialyl Tn-KLH conjugate using a 4-(4-N-maleimidomethyl) cyclohexane-1-carboxyl hydrazide (MMCCH) linker arm.
Ragupathi G; Koganty RR; Qiu D; Lloyd KO; Livingston PO
Glycoconj J; 1998 Mar; 15(3):217-21. PubMed ID: 9579798
[TBL] [Abstract][Full Text] [Related]
4. Constructing an adenocarcinoma vaccine: immunization of mice with synthetic KH-1 nonasaccharide stimulates anti-KH-1 and anti-Le(y) antibodies.
Ragupathi G; Deshpande PP; Coltart DM; Kim HM; Williams LJ; Danishefsky SJ; Livingston PO
Int J Cancer; 2002 May; 99(2):207-12. PubMed ID: 11979435
[TBL] [Abstract][Full Text] [Related]
5. Prospects for total synthesis: a vision for a totally synthetic vaccine targeting epithelial tumors.
Keding SJ; Danishefsky SJ
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):11937-42. PubMed ID: 15280546
[TBL] [Abstract][Full Text] [Related]
6. A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers.
Ragupathi G; Koide F; Sathyan N; Kagan E; Spassova M; Bornmann W; Gregor P; Reis CA; Clausen H; Danishefsky SJ; Livingston PO
Cancer Immunol Immunother; 2003 Oct; 52(10):608-16. PubMed ID: 12811527
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of a novel chemically designed (Globo)3-DTPA-KLH antigen.
Hajmohammadi M; Siadat SD; Ghorbani M; Shafiee Ardestani M; Teimourian S; Asgari V; Ahangari Cohan R; Hajmohammadi M; Hajmohammadi A; Behzadi R; Rajab Nezhad S; Namvar Asl N
Drug Des Devel Ther; 2015; 9():217-39. PubMed ID: 25565775
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer.
Dickler MN; Ragupathi G; Liu NX; Musselli C; Martino DJ; Miller VA; Kris MG; Brezicka FT; Livingston PO; Grant SC
Clin Cancer Res; 1999 Oct; 5(10):2773-9. PubMed ID: 10537341
[TBL] [Abstract][Full Text] [Related]
9. Keyhole limpet hemocyanin conjugate vaccines against cancer: the Memorial Sloan Kettering experience.
Musselli C; Livingston PO; Ragupathi G
J Cancer Res Clin Oncol; 2001 Oct; 127 Suppl 2():R20-6. PubMed ID: 11768620
[TBL] [Abstract][Full Text] [Related]
10. Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine.
Slovin SF; Ragupathi G; Musselli C; Olkiewicz K; Verbel D; Kuduk SD; Schwarz JB; Sames D; Danishefsky S; Livingston PO; Scher HI
J Clin Oncol; 2003 Dec; 21(23):4292-8. PubMed ID: 14645418
[TBL] [Abstract][Full Text] [Related]
11. Vaccination of small cell lung cancer patients with polysialic acid or N-propionylated polysialic acid conjugated to keyhole limpet hemocyanin.
Krug LM; Ragupathi G; Ng KK; Hood C; Jennings HJ; Guo Z; Kris MG; Miller V; Pizzo B; Tyson L; Baez V; Livingston PO
Clin Cancer Res; 2004 Feb; 10(3):916-23. PubMed ID: 14871967
[TBL] [Abstract][Full Text] [Related]
12. Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man.
Slovin SF; Ragupathi G; Adluri S; Ungers G; Terry K; Kim S; Spassova M; Bornmann WG; Fazzari M; Dantis L; Olkiewicz K; Lloyd KO; Livingston PO; Danishefsky SJ; Scher HI
Proc Natl Acad Sci U S A; 1999 May; 96(10):5710-5. PubMed ID: 10318949
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of synthetic conjugates of Lewis(y) oligosaccharide with proteins in mice: towards the design of anticancer vaccines.
Kudryashov V; Kim HM; Ragupathi G; Danishefsky SJ; Livingston PO; Lloyd KO
Cancer Immunol Immunother; 1998 Feb; 45(6):281-6. PubMed ID: 9490197
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity study of Globo H analogues with modification at the reducing or nonreducing end of the tumor antigen.
Lee HY; Chen CY; Tsai TI; Li ST; Lin KH; Cheng YY; Ren CT; Cheng TJ; Wu CY; Wong CH
J Am Chem Soc; 2014 Dec; 136(48):16844-53. PubMed ID: 25371992
[TBL] [Abstract][Full Text] [Related]
15. Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trial.
Gilewski T; Ragupathi G; Bhuta S; Williams LJ; Musselli C; Zhang XF; Bornmann WG; Spassova M; Bencsath KP; Panageas KS; Chin J; Hudis CA; Norton L; Houghton AN; Livingston PO; Danishefsky SJ
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3270-5. PubMed ID: 11248068
[TBL] [Abstract][Full Text] [Related]
16. Human tumor-associated Le(a)-Le(x) hybrid carbohydrate antigen IV3(Gal beta 1-->3[Fuc alpha 1-->4]GlcNAc)III3FucnLc4 defined by monoclonal antibody 43-9F: enzymatic synthesis, structural characterization, and comparative reactivity with various antibodies.
Stroud MR; Levery SB; Mårtensson S; Salyan ME; Clausen H; Hakomori S
Biochemistry; 1994 Sep; 33(35):10672-80. PubMed ID: 7521211
[TBL] [Abstract][Full Text] [Related]
17. Comparison of antibody titers after immunization with monovalent or tetravalent KLH conjugate vaccines.
Ragupathi G; Cappello S; Yi SS; Canter D; Spassova M; Bornmann WG; Danishefsky SJ; Livingston PO
Vaccine; 2002 Jan; 20(7-8):1030-8. PubMed ID: 11803062
[TBL] [Abstract][Full Text] [Related]
18. Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin.
Krug LM; Ragupathi G; Hood C; Kris MG; Miller VA; Allen JR; Keding SJ; Danishefsky SJ; Gomez J; Tyson L; Pizzo B; Baez V; Livingston PO
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6094-100. PubMed ID: 15447995
[TBL] [Abstract][Full Text] [Related]
19. Immunization of mice with fucosyl-GM1 conjugated with keyhole limpet hemocyanin results in antibodies against human small-cell lung cancer cells.
Cappello S; Liu NX; Musselli C; Brezicka FT; Livingston PO; Ragupathi G
Cancer Immunol Immunother; 1999 Dec; 48(9):483-92. PubMed ID: 10602885
[TBL] [Abstract][Full Text] [Related]
20. On the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines.
Ragupathi G; Coltart DM; Williams LJ; Koide F; Kagan E; Allen J; Harris C; Glunz PW; Livingston PO; Danishefsky SJ
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13699-704. PubMed ID: 12359877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
